MiR-133a-3p Inhibits Scar Formation in Scalded Mice and Suppresses the Proliferation and Migration of Scar Derived-fibroblasts by Targeting Connective Tissue Growth Factor

Overview

Journal Exp Anim

Date 2021 Mar 4

PMID 33658464

Citations 1

Authors

Abdul Razaq Hirman

Lili Du

Shaohang Cheng

Heng Zheng

Linna Duo

Qianyu Zhai

Jing Xu

Affiliations

Soon will be listed here.

Abstract

Excessive scar formation post burn injury can cause great pain to the patients. MiR-133a-3p has been demonstrated to be anti-fibrotic in some fibrosis-related diseases. However, its possible role in scar formation has not been elucidated yet. In present study, the effect of miR-133a-3p on scar formation was investigated in a scalded model of mice. Moreover, the function of miR-133a-3p on proliferation and migration of scar-derived fibroblasts (SFs) was studied in vitro. It was found that miR-133a-3p was dramatically downregulated in scar tissue of scalded mice. Upregulation of miR-133a-3p by miR-133a-3p agomir obviously inhibited the scar formation in scalded mice. Histological staining showed that upregulation of miR-133a-3p attenuated the excessive deposition of collagen in scar tissue of scalded mice. In vitro study showed that upregulation of miR-133a-3p effectively suppressed the proliferation and migration of SFs. Besides, upregulation of miR-133a-3p attenuated the protein levels of α-smooth muscle actin (α-SMA) and collagen I, indicating that miR-133a-3p could suppress the activation of SFs. The expression of connective tissue growth factor (CTGF), a critical mediator in cell proliferation, migration and extracellular matrix (ECM) synthesis, was also downregulated by the upregulation of miR-133a-3p. Luciferase reporter assay validated that CTGF was directly targeted by miR-133a-3p. In addition, overexpression of CTGF abolished the effect of miR-133a-3p on inhibiting the proliferation, migration and activation of SFs, indicating that miR-133a-3p functioned by targeting CTGF. Therefore, miR-133a-3p might be a promising target for treating pathological scars.

Citing Articles

α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis.

Kanno Y, Shu E Life (Basel). 2022; 12(3).

PMID: 35330147 PMC: 8953682. DOI: 10.3390/life12030396.

References

Yeoh C, Nixon J, Dickson W, Kemp A, Sibert J . Patterns of scald injuries. Arch Dis Child. 1994; 71(2):156-8. PMC: 1029951. DOI: 10.1136/adc.71.2.156. View

Yao L, Zhou B, You L, Hu H, Xie R . LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis. Mol Biol Rep. 2020; 47(4):2605-2617. DOI: 10.1007/s11033-020-05347-0. View

Jeon K, Phipps R, Sime P, Huxlin K . Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts. Exp Eye Res. 2015; 138:52-8. PMC: 4553125. DOI: 10.1016/j.exer.2015.06.028. View

Sarrazy V, Billet F, Micallef L, Coulomb B, Desmouliere A . Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 2011; 19 Suppl 1:s10-5. DOI: 10.1111/j.1524-475X.2011.00708.x. View

Abreu J, Ketpura N, Reversade B, De Robertis E . Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol. 2002; 4(8):599-604. PMC: 2387275. DOI: 10.1038/ncb826. View

Zhong L, Bian L, Lyu J, Jin H, Liu Z, Lyu L . Identification and integrated analysis of microRNA expression profiles in keloid. J Cosmet Dermatol. 2018; 17(5):917-924. DOI: 10.1111/jocd.12706. View

Babalola O, Mamalis A, Lev-Tov H, Jagdeo J . The role of microRNAs in skin fibrosis. Arch Dermatol Res. 2013; 305(9):763-76. PMC: 3979452. DOI: 10.1007/s00403-013-1410-1. View

Xiao Y, Fan P, Lei S, Qi M, Yang X . MiR-138/peroxisome proliferator-activated receptor β signaling regulates human hypertrophic scar fibroblast proliferation and movement in vitro. J Dermatol. 2015; 42(5):485-95. DOI: 10.1111/1346-8138.12792. View

Castoldi G, Di Gioia C, Bombardi C, Catalucci D, Corradi B, Gualazzi M . MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol. 2011; 227(2):850-6. DOI: 10.1002/jcp.22939. View

10.

Huang Y, Wang Y, Lin L, Wang P, Jiang L, Liu J . Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway. Mol Cell Probes. 2020; 52:101563. DOI: 10.1016/j.mcp.2020.101563. View

11.

Tuan T, Nichter L . The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998; 4(1):19-24. DOI: 10.1016/S1357-4310(97)80541-2. View

12.

Feldman K, Schaller R, Feldman J, McMillon M . Tap water scald burns in children. 1997. Inj Prev. 1998; 4(3):238-42. PMC: 1730399. DOI: 10.1136/ip.4.3.238. View

13.

Ihn H . Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002; 14(6):681-5. DOI: 10.1097/00002281-200211000-00009. View

14.

Lipson K, Wong C, Teng Y, Spong S . CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012; 5(Suppl 1):S24. PMC: 3368796. DOI: 10.1186/1755-1536-5-S1-S24. View

15.

Nakai K, Karita S, Igarashi J, Tsukamoto I, Hirano K, Kubota Y . COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis. J Dermatol Sci. 2019; 94(1):205-212. DOI: 10.1016/j.jdermsci.2019.02.003. View

16.

Guo J, Lin Q, Shao Y, Rong L, Zhang D . miR-29b promotes skin wound healing and reduces excessive scar formation by inhibition of the TGF-β1/Smad/CTGF signaling pathway. Can J Physiol Pharmacol. 2017; 95(4):437-442. DOI: 10.1139/cjpp-2016-0248. View

17.

Meng X, Nikolic-Paterson D, Lan H . TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016; 12(6):325-38. DOI: 10.1038/nrneph.2016.48. View

18.

Chujo S, Shirasaki F, Kondo-Miyazaki M, Ikawa Y, Takehara K . Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J Cell Physiol. 2009; 220(1):189-95. DOI: 10.1002/jcp.21750. View

19.

Li H, Yang L, Zhang Y, Gao Z . Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-β receptor type I. Biomed Pharmacother. 2016; 83:967-974. DOI: 10.1016/j.biopha.2016.08.011. View

20.

Liu Y, Li Y, Li N, Teng W, Wang M, Zhang Y . TGF-β1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21. Sci Rep. 2016; 6:32231. PMC: 4995376. DOI: 10.1038/srep32231. View